Analyzing the Impact of Compliance with National Guidelines for Pancreatic Cancer Care Using the National Cancer Database
Author:
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Surgery
Link
http://link.springer.com/article/10.1007/s11605-018-3742-9/fulltext.html
Reference15 articles.
1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017 67(1):7–30.
2. Kooby DA, Gillespie TW, Liu Y, Byrd-Sellers J, Landry J, Bian J, et al. Impact of adjuvant radiotherapy on survival after pancreatic cancer resection: an appraisal of data from the national cancer data base. Annals of Surgical Oncology. 2013 20 (11):3634–42.
3. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004 350(12):1200–10.
4. Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA. 2007 297(3):267–77.
5. Visser BC, Ma Y, Zak Y, Poultsides GA, Norton JA, Rhoads KF. Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes. HPB. 2012 14(8):539–47.
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A qualitative study of providers’ perspectives on cross-institutional care coordination for pancreatic cancer: challenges and opportunities;BMC Health Services Research;2024-09-09
2. Sociodemographic variation in the utilization of minimally invasive surgical approaches for pancreatic cancer;HPB;2024-07
3. Barriers to resection following neoadjuvant chemotherapy for resectable pancreatic adenocarcinoma: A national and local perspective;Journal of Surgical Oncology;2024-06-03
4. Pancreatic Cancer Health Disparity: Pharmacologic Anthropology;Cancers;2023-10-20
5. Use and accuracy of decision support systems using artificial intelligence for tumor diseases: a systematic review and meta-analysis;Frontiers in Oncology;2023-10-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3